3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Depression
3
Polycystic Ovary Syndrome
2
Depressive Disorder, Major
2
Neoplasms
1
Lymphoma, Follicular
1
Head and Neck Neoplasms
1
Asthma
1
Interventions
Cisplatin
4
Morphine
3
Fluorouracil
3
Fentanyl
3
Norepinephrine
2
Gabapentin
2
Docetaxel
2
Cetuximab
2
technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran
1
technetium Tc 99m nanocolloid
1
nimotuzumab
1
dopexamine
1
apixaban
1
Venlafaxine Hydrochloride
1
Tobacco Use Cessation Devices
1
Taste
1
Sugars
1
Saline Solution
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Psychiatric Rehabilitation
1
Pregabalin
1
Polymerase Chain Reaction
1
Patient-Specific Modeling
1
Oxycodone
1
Oral Hygiene
1
Neck Dissection
1
Mitomycin
1
Mirtazapine
1
Methadone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Head and Neck Neoplasms
×
Escitalopram
×
Clear all
NCT00536172
2023-09-21
PROTECT
University of Nebraska
Phase 4
Completed
160 enrolled
15 charts